Friday, May 9, 2008
INTERCYTEX - listed on AIM
(Alternative Investment Market) on 1 February 2006 - is developing an
integrated approach to tissue and organ replacement by
developing a series of technology platforms that will provide cost
effective intervention at a variety of points along normal
developmental pathways.
download factsheet (pdf 64kb)
